ACE2 and cancer: Among the 36 tumor types investigated, median ACE2 expression was increased in nine tumor types compared to normal tissue (0.99 TPM), with the highest ACE2 expression observed in colorectal (7.08 TPM) and kidney (5.35 TPM) cancers (Fig. 1).